Is Prasugrel a Better Antiplatelet Agent for Patients With Active Cancer and Coronary Artery Disease?
Dual antiplatelet treatment (DAPT) has emerged as the gold standard of treatment for patients with coronary artery disease (CAD). Combining two antiplatelet drugs makes sense. Aspirin inhibits the enzyme cyclooxygenase-1…
read more